Literature DB >> 22569238

Epidermal growth factor induces human oviductal epithelial cell invasion by down-regulating E-cadherin expression.

Jung-Chien Cheng1, Hsun-Ming Chang, Peter C K Leung.   

Abstract

CONTEXT: The loss of E-cadherin enhances cell invasiveness. There is increasing evidence that high-grade serous ovarian cancer may arise from oviductal epithelial cells rather than the ovarian surface epithelium. Despite the controversy over the cellular origins of this disease, the roles of epidermal growth factor (EGF) in human oviductal epithelial cells are largely unknown.
OBJECTIVE: We examined whether EGF could induce oviductal epithelial cell invasion by its down-regulation of E-cadherin.
METHODS: Matrigel-coated transwells were used for the invasion assay. Small interfering RNA was used to knock down the expression of EGF receptor (EGFR). Specific mRNA and protein levels were examined by quantitative RT-PCR and Western blot, respectively.
RESULTS: The expression of Pax8 confirmed the secretory type of the cultured human oviductal epithelial cell line OE-E6/E7. EGFR was expressed in OE-E6/E7 cells, and treatment with EGF down-regulated E-cadherin expression. The effect of EGF on the down-regulation of E-cadherin was abolished by small interfering RNA-mediated depletion of EGFR. EGF treatment led to the activation of ERK1/2, p38, and Akt. Snail and Slug are transcriptional repressors of E-cadherin. Interestingly, our results show that EGF induced Slug but not Snail expression. Moreover, the inhibition of EGF-induced ERK1/2, p38, and Akt activation by pharmacological inhibitors attenuated EGF-induced Slug expression and the down-regulation of E-cadherin, as well as subsequent cell invasion.
CONCLUSIONS: EGF induces human oviductal epithelial cell invasion through the activation of ERK1/2, p38, and Akt, the up-regulation of Slug, and the down-regulation of E-cadherin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569238     DOI: 10.1210/jc.2011-2751

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  EGF is required for cardiac differentiation of P19CL6 cells through interaction with GATA-4 in a time- and dose-dependent manner.

Authors:  Cai-Xia Ma; Yang-Liu Song; Liyun Xiao; Li-Xiang Xue; Wen-Juan Li; Brigitte Laforest; Hiba Komati; Wei-Ping Wang; Zhu-Qing Jia; Chun-Yan Zhou; Yunzeng Zou; Mona Nemer; Shan-Feng Zhang; Xiaowen Bai; Huijian Wu; Ming-Xi Zang
Journal:  Cell Mol Life Sci       Date:  2014-12-14       Impact factor: 9.261

Review 2.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

Review 3.  EGR-mediated control of STIM expression and function.

Authors:  Christina K Go; Scott Gross; Robert Hooper; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2018-12-06       Impact factor: 6.817

4.  Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.

Authors:  Wai-Kin So; Jung-Chien Cheng; Yingtao Liu; Congjian Xu; Jianfang Zhao; Vincent T W Chang; Peter C K Leung
Journal:  Tumour Biol       Date:  2016-01-14

5.  The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.

Authors:  Zaklina Kovacevic; Sharleen V Menezes; Sumit Sahni; Danuta S Kalinowski; Dong-Hun Bae; Darius J R Lane; Des R Richardson
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

6.  RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.

Authors:  Zohra Tumur; Shahbaz Katebzadeh; Carlos Guerra; Lokesh Bhushan; Tursun Alkam; Bradley S Henson
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

Review 7.  The Cross-Talk Between EGFR and E-Cadherin.

Authors:  Miguel Ramírez Moreno; Natalia A Bulgakova
Journal:  Front Cell Dev Biol       Date:  2022-01-20

8.  CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.

Authors:  Wenjie Deng; Luo Gu; Xiaojie Li; Jianchao Zheng; Yujie Zhang; Biao Duan; Jie Cui; Jing Dong; Jun Du
Journal:  J Transl Med       Date:  2016-02-01       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.